Wilson David B DB

Show results for

Unknown (70)
Transcriptomics (8)
Metabolomics (6)
Proteomics (1)

Organisms

Homo sapiens (5)
Mus musculus (4)

Repository

biostudies-arrayexpress (8)
MetaboLights (6)
PanoramaPublic (1)

Technology Type

Mass spectrometry (4)
Mass spectrometry assay (2)
NMR spectroscopy assay (1)

Instrument Platform

Liquid Chromatography MS - positive - reverse phase (3)
Liquid Chromatography MS - negative - reverse phase (3)
Liquid Chromatography MS - positive - hilic (2)
Liquid Chromatography MS - Positive (LC-MS (Positive)) (1)
Exactive (Thermo Scientific) (1)
Nuclear Magnetic Resonance (NMR) - (1)
Liquid Chromatography MS - alternating - reverse phase (1)

Publication Date

2011 (4)
2016 (2)
2022 (2)
2013 (1)
2012 (1)
2004 (1)
2025 (1)
2021 (1)
2018 (1)
2023 (1)

CHEBI ID

CHEBI:17822 (2)
CHEBI:26271 (2)
CHEBI:25094 (2)
CHEBI:22660 (2)
CHEBI:18186 (2)
CHEBI:26986 (2)
CHEBI:16811 (2)
CHEBI:28300 (2)
CHEBI:18257 (2)
CHEBI:24898 (2)
CHEBI:25017 (2)
CHEBI:15428 (2)
CHEBI:16000 (2)
CHEBI:28044 (2)
CHEBI:16865 (2)
CHEBI:27266 (2)
CHEBI:16449 (2)
CHEBI:27897 (2)
CHEBI:73138| (1)
CHEBI:132192 (1)
CHEBI:90140 (1)
CHEBI:132185 (1)
CHEBI:132184 (1)
CHEBI:132177 (1)
CHEBI:62805 (1)
CHEBI:132187 (1)
CHEBI:43619 (1)
CHEBI:131420 (1)
CHEBI:111510 (1)
CHEBI:89584 (1)

Metabolite Name

CerP(d18:1/22:0)|PC(P-16:0/P-16:0) (1)
1H-Indole, 1-(trimethylsilyl)-3-[2-[(trimethylsilyl)oxy]ethyl]- (1)
N,N-bis [2-Trimethylsiloxyethyl] ethanamine (1)
Beta-D-Galactopyranoside, methyl 2,3-bis-O-(trimethylsilyl)-, diacetate (1)
1-Cyclohexene-1-carboxylic acid, 3,4,5-tris[(trimethylsilyl)oxy]-, trimethylsilyl ester, [3R-(3alpha,4alpha,5beta)]- (1)
Myo-Inositol, 1,2,3,4,5,6-hexakis-O-(trimethylsilyl)- (1)
2-Naphthyl-beta-D-galactopyranoside (1)
D-Erythrotetrofuranose, tris-O-(trimethylsilyl)- (1)
Galactopyranose, 1,2,3,4,6-pentakis-O-(trimethylsilyl)-, beta-d- (1)
D-Galactose, 2,3,4,5,6-pentakis-O-(trimethylsilyl)- (1)
1-Butanone, 2-chloro-3-methyl-1-[4-(1-methylethyl)phenyl]- (1)
N,O-Bis-(trimethylsilyl)isoleucine (1)
Propanoic acid, 2-methyl-2-[(trimethylsilyl)oxy]-, trimethylsilyl ester (1)
Benzeneethanamine, N,alpha-dimethyl-beta-[(trimethylsilyl)oxy]- (1)
N,O-Bis-(trimethylsilyl)-2-pyrrolidone carboxylic acid (1)
2-Piperidinecarboxylic acid, 1-(trimethylsilyl)-, trimethylsilyl ester (1)
L-Leucine, N-(trimethylsilyl)-, trimethylsilyl ester (1)
Alpha-D-Mannopyranose, 1,2,3,4,6-pentakis-O-(trimethylsilyl)- (1)
Silanamine, N-[2-[3,4-bis[(trimethylsilyl)oxy]phenyl]ethyl]-1,1,1-trimethyl-N-(trimethylsilyl)- (1)
L-Aspartic acid, N-(trimethylsilyl)-, bis(trimethylsilyl) ester (1)
Butanoic acid, 2,4-bis[(trimethylsilyl)oxy]-, trimethylsilyl ester (1)
Glycine d5 (1)
L-Isoleucine, N-(trimethylsilyl)-, trimethylsilyl ester (1)
Silanamine, 1,1,1-trimethyl-N-(trimethylsilyl)-N-[2-[(trimethylsilyl)oxy]ethyl]- (1)
Pyridine, 3-trimethylsiloxy- (1)
Trisiloxane, 1,1,1,5,5,5-hexamethyl-3,3-bis[(trimethylsilyl)oxy]- (1)
4-(Trimethylsilyl)morpholine (1)
Pyridine, 3-methyl- (1)
Glycine, N-(trimethylsilyl)-, trimethylsilyl ester (1)
Cyclopentanecarboxylic acid, 1-amino-, bis(trimethylsilyl) deriv. (1)

Study type

Transcription profiling by array (8)

Release Date

2025 (14)
2022 (12)
2023 (11)
2021 (10)
2024 (8)
2011 (5)
2014 (4)
2012 (3)
2016 (2)
2013 (2)
2020 (2)
2015 (2)
2004 (1)
2026 (1)
2010 (1)

Previous page
1 / 9
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 9
Next page

Sort by:

Relevance

Page size

Transcriptome Alteration in the Diabetic Heart by Rosiglitazone: Implications for Cardiovascular Mortality

The type 2 diabetes medication, rosiglitazone, has come under scrutiny for possibly increasing the risk of cardiac disease and death. To investigate the effects of rosiglitazone on the diabetic heart, we performed cardiac transcriptional profiling of a murine model of type 2 diabetes, the C57BL/KLS...

ORGANISM(S): Mus musculus

2012-03-28 | E-GEOD-36875 | biostudies-arrayexpress

Sirtuin 5 Reduces Malonylation in Non-mitochondrial Metabolic Pathways in Diabetic Kidney Disease

Early diabetic kidney disease (DKD) is marked by dramatic metabolic reprogramming due to nutrient excess, mitochondrial dysfunction, and increased renal energy requirements from hyperfiltration. We hypothesized that changes in metabolism in DKD may be regulated by Sirtuin 5 (SIRT5), a deacylase that...

ORGANISM(S): Mus Musculus

2023-06-26 | PXD037819 | panorama

Transcriptome Analysis of Human Diabetic Kidney Disease (Control Glomeruli vs. Control Tubuli)

We identified 1,700 differentially expressed probesets in DKD glomeruli and 1,831 in diabetic tubuli; 330 probesets were commonly differentially expressed in both compartments. The canonical complement signaling pathway was determined to be statistically differentially regulated in both DKD glomerul...

ORGANISM(S): Homo sapiens

2011-08-02 | E-GEOD-30566 | biostudies-arrayexpress

Transcriptome Analysis of Human Diabetic Kidney Disease

This SuperSeries is composed of the following subset Series: GSE30528: Transcriptome Analysis of Human Diabetic Kidney Disease (DKD Glomeruli vs. Control Glomeruli) GSE30529: Transcriptome Analysis of Human Diabetic Kidney Disease (DKD Tubuli vs. Control Tubuli) GSE30566: Transcriptome Analysis of H...

ORGANISM(S): Homo sapiens

2011-08-02 | E-GEOD-30122 | biostudies-arrayexpress

Gene expression profiling in glomeruli from human kidneys with diabetic nephropathy

Gene expression profiling in glomeruli from human kidneys with diabetic nephropathy Keywords = Diabetes Keywords = kidney Keywords = glomeruli Keywords: other. This dataset is part of the TransQST collection.

ORGANISM(S): Homo sapiens

2004-04-01 | E-GEOD-1009 | biostudies-arrayexpress

Fecal microbiota transplantation plus anti-PD-1 immunotherapy in advanced melanoma: a phase I trial

Fecal microbiota transplantation (FMT) represents a potential strategy to overcome resistance to immune checkpoint inhibitors in patients with refractory melanoma; however, the role of FMT in first-line treatment settings has not been evaluated. We conducted a multicenter phase I trial combining ...

2025-02-27 | MTBLS711 | MetaboLights

Metabolic analysis of the response of Pseudomonas putida DOT-T1E strains to toluene using Fourier transform infrared spectroscopy and gas chromatography mass spectrometry

To elucidate any observable metabolic alterations during interactions of several strains of Pseudomonas putida (DOT-T1E, and its mutants DOT-T1E-PS28 and DOT-T1E-18) with the aromatic hydrocarbon toluene, metabolomic approaches were employed. Initially, Fourier-transform infrared (FT-IR) spectroscop...

2016-08-23 | MTBLS319 | MetaboLights

Transcriptome Analysis of Human Diabetic Kidney Disease (DKD Glomeruli vs. Control Glomeruli)

ORGANISM(S): Homo sapiens

2011-08-02 | E-GEOD-30528 | biostudies-arrayexpress

Transcriptome Analysis of Human Diabetic Kidney Disease (DKD Tubuli vs. Control Tubuli)

ORGANISM(S): Homo sapiens

2011-08-02 | E-GEOD-30529 | biostudies-arrayexpress

Deficient Endoplasmic Reticulum-Mitochondrial Phosphatidylserine Transfer Causes Liver Disease

Non-alcoholic fatty liver is the most common liver disease worldwide. Here, we show that the mitochondrial protein mitofusin 2 (Mfn2) protects against liver disease. Reduced Mfn2 expression was detected in liver biopsies from patients with non-alcoholic steatohepatitis (NASH). Moreover, reduced Mfn2...

2018-01-25 | MTBLS600 | MetaboLights

Previous page
1 / 9
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 9
Next page

Sort by:

Relevance

Page size

85 Results

Show results for

Organisms

Repository

Technology Type

Instrument Platform

Publication Date

CHEBI ID

Metabolite Name

Study type

Release Date

OmicsDI is part of the ELIXIR infrastructure

Tweets